What are the contraindications for the use of gaffetuzumab?

Glofitamab is a new type of immunotherapy drug mainly used to treat patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL; non-Hodgkin lymphoma) and follicular lymphoma (FL). As a bispecific antibody, gaffetumumab can guide T cells to attack tumor cells by simultaneously targeting CD20 and CD3, thereby effectively inhibiting the growth of cancer. However, despite the significant efficacy of this drug, patients still need to follow strict contraindications and precautions during use to ensure the safety of the treatment.

First, one of the contraindications to the use of gaffetuzumab is in patients with a known allergy to the drug or any of its components. Anaphylaxis may result in serious side effects such as anaphylactic shock or other immune reactions, so all patients should have an allergy history evaluated before starting treatment.

In addition, gaffetuzumab may cause cytokine release syndrome (CRS), a serious side effect associated with activation of the immune response. Symptoms of CRS may include fever, low blood pressure, difficulty breathing, and organ failure. Therefore, patients with severe heart disease, lung disease, or other serious health problems need to be carefully evaluated and monitored carefully before using gaffetuzumab. For these patients, use of gaffetuzumab may increase the risk of serious infections and other complications.

The use of gaffetuzumab requires special attention in combination with other immunosuppressants, especially in patients whose immune systems have been suppressed. These patients may be at increased risk for infection and should avoid coadministration with other immunosuppressive drugs unless specifically directed by their physician.

In short, the contraindications for the use of gaffetuzumab mainly focus on allergic reactions, immune system suppression and the risk ofCRS. Patients need to fully communicate with their doctors when using this drug to ensure a treatment plan that is suitable for them. Regular monitoring and timely management of side effects are essential to optimize treatment effectiveness.

Reference materials:https://www.drugs.com/glofitamab.html